Clinical Trials Browser

Lymphoma, Large B-Cell, Diffuse

Pancreatic Neoplasms

Lymphoma, T-Cell, Peripheral

Lymphoma, T-Cell, Peripheral

Leukemia, Myeloid, Acute

Lymphoma, T-Cell, Peripheral

Leukemia, Monocytic, Acute

Lymphoma, T-Cell, Peripheral

Leukemia, Myeloid, Acute

Leukemia, Myeloid, Acute

Lymphoma, T-Cell, Peripheral

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Advanced Colorectal Cancer in the Third-line Treatment and Beyond

Lymphoma, Large B-Cell, Diffuse

Recurrence, Lymphoma, T-Cell, Peripheral

Leukemia, Myeloid, Acute

Lymphoma, T-Cell, Peripheral

Colorectal Cancer Metastatic

Sarcoma, Osteosarcoma

Lymphoma, T-Cell

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin

Leukemia, Myeloid, Acute, Neoplasm, Residual

HR+/HER2- Advanced Breast Cancer

Leukemia, Myeloid, Acute

Lymphoma, Non-Hodgkin

Clinical Trials

CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL

QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer

A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma

CM-AML-001

Linperlisib Combined With Chidamide in Patients With PTCL

Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia

A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)

Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML

Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse

Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients

The Aim of This Study is to Assess the Efficacy and Safety of Chidamide, Regorafenib in Combination With Iparomlimab and Tuvonralimab for the Treatment of Advanced Colorectal Cancer in Third-line Therapy and Subsequent Lines.

HiR+X

Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)

VAC Regimen for AML Patients Who Failed to Response to VA Regimen

Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma

Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion

Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS/pMMR Metastatic Colorectal Cancer

Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma

Tucidinostat, Azacitidine Combined With CHOP Versus CHOP in Patients With Untreated Peripheral T-cell Lymphoma

Chidamide Bridging for CAR-T Therapy

APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma

A Study of Chidamide With AZA in MRD Positive AML After Transplant

Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer

Chidamide Prevents Recurrence of High-risk AML After Allo-HSCT

Chidamide in Combination With Decitabine in Non-Hodgkin's Lymphoma Relapsed After Chimeric Antigen Receptor